{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-007109","form_type":"8-K","ticker":"BLGO","cik":"0000880242","company_name":"BIOLARGO, INC.","filed_at":"2022-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.135334+00:00","generated_at":"2026-06-26T19:06:31.439500+00:00","sec_items":["1.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BioLargo extends CFO engagement through Jan 2023; grants 300k-share option at $0.24","bullets":["CFO Charles K. Dargan II engagement extended one year to January 31, 2023.","Sole compensation: option to purchase 300,000 shares (25,000/month) at $0.24 per share.","Option vests monthly beginning March 2022; no cash compensation for the term.","Option granted under 2018 Equity Incentive Plan, expires ten years from grant date.","Either party can terminate the agreement with 30 days' written notice."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-007109","json":"https://secwatch.observer/filing/0001437749-22-007109.json","markdown":"https://secwatch.observer/filing/0001437749-22-007109.md","text":"https://secwatch.observer/filing/0001437749-22-007109.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/880242/000143774922007109/0001437749-22-007109-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/880242/000143774922007109/blgo20220323_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T19:06:31.439500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}